The opioid epidemic is helping reduce prescriptions for opioid-based pharmacotherapy. However, parallel to this drop has been an increase in gabapentin and pregabalin prescriptions.  Why has this occurred and what should the clinician know about this phenomenon? Additional Resources/References: Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016. Zhou L, Bhattacharjee S, Kwoh CK, Tighe PJ, Malone DC, Slack M, Wilson DL, Brown JD, Lo-Ciganic WH. J Clin Med. 2019 Dec 29;9(1):83. doi:10.3390/jcm9010083. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices